KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Accumulated Depreciation: 2009-2025

Historic Accumulated Depreciation for National Health Investors (NHI) over the last 14 years, with Jun 2025 value amounting to $781.4 million.

  • National Health Investors' Accumulated Depreciation rose 10.71% to $781.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $781.4 million, marking a year-over-year increase of 10.71%. This contributed to the annual value of $742.3 million for FY2024, which is 10.25% up from last year.
  • Latest data reveals that National Health Investors reported Accumulated Depreciation of $781.4 million as of Q2 2025, which was up 2.62% from $761.5 million recorded in Q1 2025.
  • In the past 5 years, National Health Investors' Accumulated Depreciation registered a high of $781.4 million during Q2 2025, and its lowest value of $582.2 million during Q1 2022.
  • Moreover, its 3-year median value for Accumulated Depreciation was $698.3 million (2024), whereas its average is $698.0 million.
  • In the last 5 years, National Health Investors' Accumulated Depreciation grew by 15.59% in 2021 and then decreased by 5.84% in 2022.
  • National Health Investors' Accumulated Depreciation (Quarterly) stood at $593.2 million in 2021, then climbed by 1.05% to $599.4 million in 2022, then grew by 9.46% to $656.2 million in 2023, then rose by 10.28% to $723.6 million in 2024, then rose by 10.71% to $781.4 million in 2025.
  • Its Accumulated Depreciation stands at $781.4 million for Q2 2025, versus $761.5 million for Q1 2025 and $723.6 million for Q3 2024.